SPONSOR
University of Virginia
Total Trials
13
Recruiting
13
Phases
Phase 1, Phase 2, Phase 1, EARLY_Phase 1, Phase 2, Phase 4, Phase 2, Phase 3
Conditions studied: Breast CancerProstate CancerAngina Patients With Non-obstructive Coronary Artery DiseaseCoronary Microvascular DiseaseCoronary Microvascular Dysfunction (CMD)Smoking CessationSmoking, CigaretteSmoking ReductionSmokingSmoking, Tobacco
University of Virginia is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Breast Cancer, Prostate Cancer, Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease.
The trial portfolio spans Phase 1, Phase 2, Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Virginia
How many clinical trials has University of Virginia sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University of Virginia, of which 13 are actively recruiting participants. These trials cover conditions including Breast Cancer, Prostate Cancer, Angina Patients With Non-obstructive Coronary Artery Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Virginia research focus on?
University of Virginia clinical trials span Breast Cancer, Prostate Cancer, Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease, Coronary Microvascular Dysfunction (CMD), and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Virginia clinical trial?
To participate in a University of Virginia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Virginia trials with current recruitment status updated daily.
Clinical Trials by University of Virginia
NCT07441889 Phase 1, Phase 2
Recruiting
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Breast Cancer
NCT06600178 Phase 1
Recruiting
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Angina Patients With Non-obstructive Coronary Artery Disease
NCT05660525
Recruiting
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
Smoking Cessation
NCT04904757
Recruiting
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
Mammographic Breast Density
NCT03401047 EARLY_Phase 1
Recruiting
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
NCT06903923 Phase 2
Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Obesity in Children
NCT06810336 EARLY_Phase 1
Recruiting
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery
Brain Injury
NCT07298941 Phase 2
Recruiting
Resilience Enhancement Following Sleep Treatment
Chronic Low Back Pain (CLBP)
NCT07046910 Phase 2
Recruiting
Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection
Lung Transplant Rejection
NCT07146685 Phase 4
Recruiting
Effect of Local Anesthetic Concentration on Rebound Pain
Rebound Pain
NCT07405645
Recruiting
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
Head Neck Cancer
NCT05288777 Phase 2, Phase 3
Recruiting
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
Breast Cancer
NCT07178145 Phase 4
Recruiting
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
Heart Failure Preserved Ejection Fraction
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology